Source: Clinics. Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP". Unidade: FM
Subjects: ÓXIDO NÍTRICO, SOLUÇÕES ELETROLÍTICAS, MODELOS ANIMAIS, RATOS, DOENÇA CRÔNICA (PREVENÇÃO E CONTROLE), ABLAÇÃO ANIMAL, NEFROPATIAS (PREVENÇÃO E CONTROLE), RESUMOS (EVENTOS)
ABNT
SOUSA, L B et al. Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 13 nov. 2024. , 2010APA
Sousa, L. B., Okabe, C., Sena, C. R., Ventura, B. H., Fanelli, C., Malheiros, D. M. A. C., et al. (2010). Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.NLM
Sousa LB, Okabe C, Sena CR, Ventura BH, Fanelli C, Malheiros DMAC, Zatz R, Fujihara CK. Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. 2010 ; 65 S56.[citado 2024 nov. 13 ]Vancouver
Sousa LB, Okabe C, Sena CR, Ventura BH, Fanelli C, Malheiros DMAC, Zatz R, Fujihara CK. Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. 2010 ; 65 S56.[citado 2024 nov. 13 ]